Delaware Clinical and Translational Research ACCEL Program (Professional Development Core)

摘要-专业发展核心 特拉华州CTR ACCEL项目的主要目标包括促进临床和转化研究 (CTR)跨学科和提高教师的竞争力的研究经费。ACCEL PDC拥有 寻求接触，连接和支持临床科学家和初级教师，因为他们追求他们的第一个赠款- 包括转手资金（例如，ACCEL或其他IDEA计划试点奖）或外部基金（例如，K 奖、COBRE目标项目、基金会赠款或R赠款）。ACCEL-CTR专业发展核心 (PDC)旨在支持CTR研究者的发展。PDC已经成功建立了 计划，包括指导研究发展奖（MRDA），全州青少年的赞助， 研究者网络（JIN），以及与DE IDEA国家临床试验网络和DE IN的合作- BRE。在ACCEL 3中，我们加强了现有的计划，并增加了三个关键计划：（一）综合导师培训- 支持新兴的研究者，扩大我们的临床研究导师基础，部署最佳实践， 确保多样性、公平性和包容性;（ii）帮助新手调查人员识别和引导监管改革的工具; 要求，行政程序和资源的临床研究;（iii）一个更有组织和自给自足， 加强同行的支持和合作计划的发展。ACCEL 3中的PDC有三个 具体目标。目标1：提供综合导师培训和支持计划。PDC将提供重新- 资源和培训，并将在ACCEL机构安装“导师冠军”，以支持当地导师， 支持教师与ACCEL的参与，并确保ACCEL教师之间的多样性和包容性。目的 2.实施成功之路计划。克服临床研究常见障碍的资源 将作为自我指导工具部署，详细说明与ACCEL教师相关的流程，并在以下方面提供指导： 需要的领域。目标3：在我们的JIN中发展对等分组。PDC将与JIN合作，以确定特殊- 社会利益小组，特别是代表性不足的教师群体，并提供同行计划和教育， 资源丰富。目标4：加强现有方案，进一步提高外部资金的竞争力- ing.旨在帮助教师制定强有力的赠款提交的现有PDC计划将得到加强， 提供有针对性的支持。PDC由Robert Akins和一个有代表的成功团队领导 来自ACCEL的多个学科。PDC目标的执行将促进专业发展， ACCEL研究者，增加外部资金的竞争力，并支持更有效的临床和 翻译研究指导，充分拥抱整个ACCEL的多样性，公平和包容的戒律。 页1的1

ABSTRACT – PROFESSIONAL DEVELOPMENT CORE Primary goals of the Delaware CTR ACCEL program include facilitating clinical and translational research (CTR) across disciplines and increasing faculty competitiveness for research funding. The ACCEL PDC has sought to reach, connect, and support clinician scientists and junior faculty as they pursue their first grants in- cluding pass-through funding (e.g., an ACCEL or other IDeA program pilot award) or external funds (e.g., K award, COBRE target project, foundation grant, or R grant). The ACCEL-CTR Professional Development Core (PDC) was established to support the development of CTR investigators. The PDC has established successful programs, including Mentored Research Development Awards (MRDA), sponsorship of a statewide Junior In- vestigators’ Network (JIN), and collaborations with the DE IDeA States Clinical Trials Network and the DE IN- BRE. In ACCEL3, we enhance our existing programs and add three key programs: (i) integrated mentor train- ing to support emerging investigators, expand our base of clinical research mentors, deploy best practices, and assure diversity, equity, and inclusion; (ii) tools to help novice investigators identify and navigate regulatory re- quirements, administrative processes, and resources for clinical studies; (iii) a more organized and self-suffi- cient JIN to enhance peer support and collaborative program development. The PDC in ACCEL3 has three Specific Aims. Aim 1: Provide integrated mentor training and support programs. The PDC will provide re- sources and training, and “Mentor Champions” will be installed at ACCEL institutions to support local mentors, support the engagement of faculty with ACCEL, and assure diversity and inclusion among ACCEL faculty. Aim 2: Implement a Pathways to Success program. Resources to overcome common barriers to clinical research will be deployed as self-guided tools detailing processes relevant to ACCEL faculty and providing coaching in areas of need. Aim 3: Develop peer subgroups within our JIN. The PDC will work with the JIN to identify spe- cial interest subgroups, especially groups of underrepresented faculty, and to provide peer programs and edu- cational resources. Aim 4: Strengthen existing programs to further increase competitiveness for external fund- ing. Existing PDC programs designed to help faculty develop strong grant submissions will be enhanced to provide targeted support. The PDC is led by Robert Akins and an accomplished team with representatives from multiple disciplines across ACCEL. Execution of PDC aims will advance the professional development of ACCEL investigators, increase competitiveness for external funding, and support a more effective clinical and translational research mentoring that fully embraces precepts of diversity, equity, and inclusion across ACCEL. Page 1 of 1